Selenium Deficiency
Conditions
Keywords
Selenium supplements, Selenoprotein P, Optimization
Brief summary
The purpose of this study is to determine the amount of selenium as selenomethionine that is required to optimize selenoprotein P in selenium-deficient Chinese subjects
Detailed description
Selenium is an essential nutrient. The Recommended Dietary Allowance (RDA) for selenium is considered to be the amount required to optimize plasma selenoproteins. There are two selenoproteins present in the plasma: selenoprotein P (Se-P) and glutathione peroxidase 3 (GPX-3). Although the amount of selenium required to optimize GPX-3 has been determined, the amount required to optimize Se-P in the plasma remains unknown. We aim to determine this amount by supplementing selenium deficient subjects with varying amounts of selenium as selenomethionine. The study will take place in Mianning County, China, where selenium status is low. Approximately 150 people will be screened for eligibility to participate in this study. 98 subjects will be enrolled. Background information obtained from each participant will be: age, height, weight and smoking status. Subjects will be randomized to a selenium supplement group. The selenium supplement will contain either 0, 20, 40, 60, 80, 100, or 120 µg of selenium as selenomethionine. A CDC worker will visit each participant daily to give them their selenium supplement. The CDC worker will watch them take their supplement and will ask if they have any unanticipated problems. Blood samples of 20 ml will be obtained at weeks 0, 4, 8, 12, 16, 20, 24, 32, and 40. Hair samples and 24-hr urine collections will be obtained at 0, 20 and 40 weeks. The total study duration is 40 weeks.
Interventions
20 µg selenium as selenomethionine
40 µg selenium as selenomethionine
60 µg selenium as selenomethionine
80 µg selenium as selenomethionine
100 µg selenium as selenomethionine
120 µg selenium as selenomethionine
placebo
Sponsors
Study design
Eligibility
Inclusion criteria
* aged 17 years or older * healthy * resident of Mianning County for at least 1 year * hematocrit (PCV) of 30 or greater
Exclusion criteria
* subject has taken selenium supplements within the year prior to study * subject plans to relocate during study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma selenoprotein P levels at 0, 4, 8, 12, 16, 20, 24, 32, and 40 weeks | 40 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Total plasma selenium concentrations at 0, 4, 8, 12, 16, 20, 24, 32, and 40 weeks | 40 weeks |
| Plasma glutathione peroxidase activity at 0, 4, 8, 12, 16, 20, 24, 32, and 40 weeks | 40 weeks |
| 24hr urinary selenium excretion at 0, 20 and 40 weeks | 40 weeks |
| Hair selenium levels at 0, 20 and 40 weeks | 40 weeks |
Countries
China